Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ZAI Lab
Pharma
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
AZ executives past and present are under investigation in China. GSK obtained a T-cell engager for lupus. Takeda hit a orexin setback. And more.
Angus Liu
Nov 1, 2024 8:20am
BMS partner Zai Lab eyes China filing for KarXT after trial win
Oct 29, 2024 1:59pm
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Oct 25, 2024 8:43am
FDA signs off on Innoviva's Xacduro for bacterial pneumonia
May 24, 2023 10:25am
Eisai, Astellas and Samsung Biologics—Fierce Pharma Asia
Jan 13, 2023 7:45am
Enhertu, Hutchmed, BeiGene-Novartis—Fierce Pharma Asia
Aug 12, 2022 9:50am
